Global Anti-Suicide Drugs Market Was Valued at US$ 3,318.3 Mn in 2015 and is Expected to be US$ 4,846.9 Mn by 2024, Growing at CAGR of 4.2% From 2016 to 2024

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Latest report titled “Anti-Suicide Drugs Market – Insights, Trends, Outlook, And Opportunity Analysis, 2014–2024” predicts Global anti-suicide drugs market to be US$ 4,846.9 Mn by 2024, growing at CAGR of 4.2% from 2016 to 2024.

The most recent report available at Market Reports Center titled, Anti-Suicide Drugs Market – Insights, Trends, Outlook, And Opportunity Analysis, 2014–2024, forecast that the Anti-Suicide Drugs Market size is estimated to prosper at a significant CAGR of 4.2% in the future, and this is because of the growing numbers of suicide incidences around the world are likely to further the industry increase for anti-suicide drugs during the estimated time.

Check more details about the report at

As per the latest report, the Global Anti-suicide Drugs Market is anticipated to exhibit growth with a CAGR of 4 % over the projected timeframe (2016-2024). The growing numbers of suicide incidences around the world are likely to further the industry increase for anti-suicide drugs during the estimated time. This comprehensive report includes in-depth analysis of the anti-suicide drugs. This study provides market size (US$ Million) and CAGR (Cumulative Annual Growth Rate %) for the projected time frame. This report also analyzes market drivers, restraints, challenges and opportunities, regional outlook, new product launches or approval, and competitive landscape of the market.

Suicide is said to be one of the key economic burdens to the global economy. The majority of the suicidal deaths occur in Eastern Europe, Asia, and Africa. Several causative factors for suicide include depression, substance abuse, financial crisis, no hope in life, bipolar disorder, post-traumatic stress disorder, etc. In addition to this, an overdose of opioids, or side effects of anti-depressants may also lead to suicidal attempts. Furthermore, most of the suicides go overlooked until and not often are reported to suicidal prevention organizations. Such organizations can help ease the problems and prevent suicides. Growing incidences of suicidal attempts and deaths are likely to stimulate the growth of anti-suicide drugs market. The introduction of FDA permitted anti-suicidal drugs post 2020 is likely to hamper the industry progress for anti-anxiety drugs and anti-depressants.

Get the Discount Code at

The report covers analysis of the market segmented by geographical scale. Major regions including North America, Europe, Asia-Pacific, Latin America, Middle East, Africa and their sub-segments are studied in the report. The anti-suicide drugs market in Europe and North America is projected to witness noteworthy traction post the introduction of the anti-suicidal drug. The growth is attributed to factors including growing prevalence of suicides in the region and growing healthcare expenditure in emerging economies. Furthermore, developed regions propose superior healthcare infrastructure and usually adopt new therapies quickly. Companies are expected to take advantage of lucrative opportunities in these regions, and this is likely to contribute to sustained growth shortly.

The report features key players in the global anti-suicide drugs market profiled in the report including product portfolio, company overview, geographical presence, financial performance, distribution strategies, key trends, developments, key strategies adopted as well as plans. Some of the prominent names covered as a part of this study comprise of Allergan plc, Pfizer, Inc., Johnson & Johnson, Eli Lilly and Company, AstraZeneca plc, Merck & Co., Inc., GlaxoSmithKline plc, NeuroRx, Inc., and Lundbeck A/S.

Key insights from this report will provide exact details about the market and guide marketers and the management of companies to make a well-informed decision regarding competitive scenario, future product launch, marketing tactics, and geographic expansion.

The report covers a detailed analysis of anti-suicide drugs market by using various strategy matrices, which can help stakeholders to make strategic decisions accordingly. The emergence of novel approved drugs, likely to be commercialized post-2020, proposed for treatment of suicidal ideation is expected to be a key point for the global anti-suicide drugs market.

Download sample pages at

About Market Reports Center:

Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.

Market Reports Center currently has more than 300,000 plus titles and 40+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)